Outline of Salivary Gland Pathogenesis of Sjögren's Syndrome and Current Therapeutic Approaches
- PMID: 37446355
- PMCID: PMC10342367
- DOI: 10.3390/ijms241311179
Outline of Salivary Gland Pathogenesis of Sjögren's Syndrome and Current Therapeutic Approaches
Abstract
Sjögren's syndrome (SS) is an autoimmune disease characterized by the involvement of exocrine glands such as the salivary and lacrimal glands. The minor salivary glands, from which tissue samples may be obtained, are important for the diagnosis, evaluation of therapeutic efficacy, and genetic analyses of SS. In the onset of SS, autoantigens derived from the salivary glands are recognized by antigen-presenting dendritic cells, leading to the activation of T and B cells, cytokine production, autoantibody production by plasma cells, the formation of ectopic germinal centers, and the destruction of salivary gland epithelial cells. A recent therapeutic approach with immune checkpoint inhibitors for malignant tumors enhances the anti-tumor activity of cytotoxic effector T cells, but also induces SS-like autoimmune disease as an adverse event. In the treatment of xerostomia, muscarinic agonists and salivary gland duct cleansing procedure, as well as sialendoscopy, are expected to ameliorate symptoms. Clinical trials on biological therapy to attenuate the hyperresponsiveness of B cells in SS patients with systemic organ involvement have progressed. The efficacy of treatment with mesenchymal stem cells and chimeric antigen receptor T cells for SS has also been investigated. In this review, we will provide an overview of the pathogenesis of salivary gland lesions and recent trends in therapeutic approaches for SS.
Keywords: Sjögren’s syndrome; biological therapy; immune checkpoint inhibitor; monoclonal antibody; muscarinic agonist; pathogenesis; salivary gland; sialendoscopy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342367/bin/ijms-24-11179-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342367/bin/ijms-24-11179-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342367/bin/ijms-24-11179-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342367/bin/ijms-24-11179-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342367/bin/ijms-24-11179-g005.gif)
Similar articles
-
The Significance of Ectopic Germinal Centers in the Minor Salivary Gland of Patients with Sjögren's Syndrome.J Korean Med Sci. 2016 Feb;31(2):190-5. doi: 10.3346/jkms.2016.31.2.190. Epub 2016 Jan 13. J Korean Med Sci. 2016. PMID: 26839471 Free PMC article.
-
Genetic associations to germinal centre formation in primary Sjogren's syndrome.Ann Rheum Dis. 2014 Jun;73(6):1253-8. doi: 10.1136/annrheumdis-2012-202500. Epub 2013 Apr 20. Ann Rheum Dis. 2014. PMID: 23606706
-
CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.Rheumatology (Oxford). 2014 Apr;53(4):611-20. doi: 10.1093/rheumatology/ket401. Epub 2013 Dec 9. Rheumatology (Oxford). 2014. PMID: 24324211
-
Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.Int J Mol Sci. 2018 Oct 30;19(11):3392. doi: 10.3390/ijms19113392. Int J Mol Sci. 2018. PMID: 30380700 Free PMC article. Review.
-
Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment.Front Immunol. 2022 Oct 28;13:995895. doi: 10.3389/fimmu.2022.995895. eCollection 2022. Front Immunol. 2022. PMID: 36389806 Free PMC article. Review.
Cited by
-
Role of ncRNAs in the Pathogenesis of Sjögren's Syndrome.Biomedicines. 2024 Jul 11;12(7):1540. doi: 10.3390/biomedicines12071540. Biomedicines. 2024. PMID: 39062113 Free PMC article. Review.
-
Update on the pathophysiology and treatment of primary Sjögren syndrome.Nat Rev Rheumatol. 2024 Aug;20(8):473-491. doi: 10.1038/s41584-024-01135-3. Epub 2024 Jul 9. Nat Rev Rheumatol. 2024. PMID: 38982205 Review.
-
Basement Membrane Mimetic Hydrogel Cooperates with Rho-Associated Protein Kinase Inhibitor to Promote the Development of Acini-Like Salivary Gland Spheroids.Adv Nanobiomed Res. 2023 Nov;3(11):2300088. doi: 10.1002/anbr.202300088. Epub 2023 Oct 8. Adv Nanobiomed Res. 2023. PMID: 38645834
-
Endothelial Dysfunction in Primary Sjögren's Syndrome: Correlation with Serum Biomarkers of Disease Activity.Int J Mol Sci. 2023 Sep 10;24(18):13918. doi: 10.3390/ijms241813918. Int J Mol Sci. 2023. PMID: 37762225 Free PMC article.
References
-
- Shiboski C.H., Shiboski S.C., Seror R., Criswell L.A., Labetoulle M., Lietman T.M., Rasmussen A., Scofield H., Vitali C., Bowman S.J., et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017;69:35–45. doi: 10.1002/art.39859. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical